Cognition Therapeutics CGTX
NASDAQ CGTX
$0.91 +0.02 (+2.51%)
As of: Oct 2, 2026 · 10:12 AM EDT

Cognition Therapeutics (CGTX) Short-Term Debt repayments (2022 - 2026)

Updated

Cognition Therapeutics (CGTX) recorded Short-Term Debt repayments of $116,000 in Q2 2026, down 3.3% from $120,000 a year earlier but up 2.7% from the prior quarter.

Analysis

Cognition Therapeutics (CGTX) Short-Term Debt repayments (2022 - 2026) Analysis & Trends

On a TTM basis, Cognition Therapeutics' Short-Term Debt repayments came in at $344,000 as of Jun 30, 2026, down 44.3% year-over-year; for FY2025, it was $353,000, down 52.2% from FY2024.

  • Annual Short-Term Debt repayments has declined for three straight years, though with a four-year compound annual growth rate of 7.1% (FY2021 to FY2025).
  • Across earlier years, Short-Term Debt repayments came in at $739,000 in FY2024 (-8.9%), $811,000 in FY2023 (-41.9%), $1.4 million in FY2022 (+420.9%) and $268,000 in FY2021.
  • Quarterly Short-Term Debt repayments has ranged from $41,000 in Q3 2025 to $401,000 in Q3 2022 over the past five years.
  • On a year-over-year basis, Short-Term Debt repayments has declined for six consecutive quarters, with an average decline of 27.5% over the last eight quarters.
  • Peak year-over-year performance for Short-Term Debt repayments in the last five years was growth of 8.9% in Q4 2024, against a decline of 77.8% in Q3 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $113,000 (Q1 2026), $74,000 (Q4 2025) and $41,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Repayment (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 6.45 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Cognition Therapeutics 91.25 Mn 91.25 Mn - 116,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 116,000.00
Mar 31, 2026 113,000.00
Dec 31, 2025 74,000.00
Sep 30, 2025 41,000.00
Jun 30, 2025 120,000.00
Mar 31, 2025 118,000.00
Dec 31, 2024 195,000.00
Sep 30, 2024 185,000.00
Jun 30, 2024 181,000.00
Mar 31, 2024 178,000.00
Dec 31, 2023 179,000.00
Sep 30, 2023 215,000.00
Jun 30, 2023 210,000.00
Mar 31, 2023 207,000.00
Dec 31, 2022 205,000.00
Sep 30, 2022 401,000.00
Jun 30, 2022 396,000.00
Mar 31, 2022 394,000.00
API Access

Cognition Therapeutics Short-Term Debt repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-repayments&ticker=CGTX&period=max&api_key=YOUR_API_KEY